| Literature DB >> 23765386 |
Thais Nascimento, Fernanda Mota, Luis Felipe Neves dos Santos, Sérgio de Araújo, Mieko Okada, Marcello Franco, Angelo A V de Paola, Guilherme Fenelon.
Abstract
BACKGROUND: EnSiteNavx electroanatomic mapping system is widely used in radiofrequency (RF) atrial fibrillation ablation, helping the creation of linear lesions. However, the correspondence of the virtual line created by EnSite with the pathological lesion has not yet been evaluated.Entities:
Mesh:
Year: 2013 PMID: 23765386 PMCID: PMC3998150 DOI: 10.5935/abc.20130127
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Image of the intracardiac echocardiogram during transseptal puncture. The red arrow indicates the tent formed in the interatrial septum immediately after the puncture. A: right atrium. B: left atrium.
Characteristics of the animals (n = 10), radiofrequency application parameters and size of lesion lines when an 8mm-tip catheter is used
| 32/31 | RA | 52 ± 6.0 | 62 ± 15.9 | 603 | 1 | 4.0 | 0.8 | |
| LA | 56 ± 8.2 | 59 ± 16.0 | 528 | 1 | 4.0 | 0.9 | ||
| 36/48.6 | RA | 55 ± 5.6 | 50 ± 23.6 | 505 | 2 | 3.5/4.0 | 0.8/0.9 | |
| LA | 54 ± 5.9 | 63 ± 15.8 | 488 | 1 | 5.0 | 0.9 | ||
| 32/41 | RA | 49 ± 8.4 | 68 ± 5.2 | 420 | 2 | 3.0/3.0 | 0.5/0.6 | |
| LA | 55 ± 6.6 | 45 ± 23.3 | 519 | 2 | 4.0/3.0 | 0.8/0.7 | ||
| 40/42 | RA | 52 ± 5.0 | 65 ± 11.7 | 468 | 2 | 4.0/3.0 | 0.8/0.6 | |
| LA | 57 ± 4.2 | 45 ± 21.3 | 510 | 2 | 3.5/3.4 | 0.6/0.7 | ||
| 38/44 | RA | 58 ± 4.3 | 52 ± 22.0 | 503 | 2 | 4.0/3.5 | 0.8/0.5 | |
| LA | 57 ± 4.8 | 40 ± 22.8 | 510 | 2 | 3.0/3.0 | 0.5/0.6 | ||
| 42/42 | RA | 54 ± 7.9 | 45 ± 25.3 | 487 | 1 | 5.5 | 1.2 | |
| LA | 56 ± 6.8 | 41 ± 28.4 | 520 | 2 | 3.5/3.0 | 0.5/0.6 | ||
| 35/31 | RA | 51 ± 8.3 | 55 ± 23.8 | 526 | 2 | 3.5/3.0 | 0.8/0.7 | |
| LA | 58 ± 3.4 | 57 ± 14.1 | 496 | 2 | 3.0/3.0 | 0.5/0.5 | ||
| 35/40 | RA | 49 ± 8.8 | 65 ± 9.3 | 530 | 1 | 3.6 | 0.5 | |
| LA | 45 ± 18.5 | 56 ± 19.4 | 540 | 1 | 3.6 | 0.5 | ||
| 39.6/33 | RA | 57 ± 5.2 | 49 ± 15.8 | 505 | 1 | 5.0 | 0.9 | |
| LA | 53 ± 6.3 | 58 ± 20.6 | 497 | 1 | 4.0 | 0.8 | ||
| 36/34 | RA | 55 ± 4.7 | 57 ± 19.3 | 627 | 2 | 3.5/3.0 | 0.8/0.6 | |
| LA | 58 ± 17.8 | 55 ± 5.6 | 543 | 1 | 5.5 | 1.1 | ||
| 36.5 ± 3.3/ 38.7 ± 6.0 | RA | 50.2 ± 9.14 | 54.4 ± 20.8 | 517.4 ± 60.5 | 16 | 3.09 ± 0.73 | 0.69 ± 0.24 | |
| LA | 54.6 ± 8.02 | 53.7 ± 21.3 | 515.1 ± 18.5 | 15s | 3.63 ± 0.77 | 0.68 ± 0.19 | ||
RA: right atrium; LA: left atrium; P: power; RF: radiofrequency; T: temperature.
Characteristics of the animals (n = 4), radiofrequency application parameters and size of lesion lines when an irrigated-tip catheter is used
| 32/39.5 | RA | 36 ± 1.5 | 40 ± 0.8 | 548 | 2 | 3.5/3.0 | 0.7/0.7 | |
| LA | 37 ± 2.9 | 40 ± 0.5 | 468 | 1 | 4.0 | 0.7 | ||
| 36/39.8 | RA | 38 ± 3.6 | 40 ± 1.6 | 512 | 2 | 3.5/3.0 | 0.7/0.5 | |
| LA | 38 ± 4.2 | 39 ± 1.9 | 347 | 2 | 4.0/3.3 | 0.8/0.6 | ||
| 35/43.5 | RA | 37 ± 2.7 | 40 ± 0.9 | 525 | 2 | 3.0/3.0 | 0.5/0.5 | |
| LA | 36 ± 4.2 | 40 ± 2.4 | 506 | 2 | 3.5/3.0 | 0.9/1.1 | ||
| 36/38 | RA | 38 ± 3.2 | 40 ± 1.2 | 488 | 1 | 5.5 | 1.0 | |
| LA | 38 ± 4.3 | 38 ± 3.7 | 509 | 1 | 3.5 | 0.6 | ||
| 34.8 ± 1.9/ 40.2 ± 2.3 | RA | 37.2 ± 2.98 | 39.7 ± 1.19 | 518.2 ± 25.0 | 7 | 3.50 ± 0.91 | 0.65 ± 0.18 | |
| LA | 37.3 ± 4.01 | 39.3 ± 2.55 | 457.5 ± 76.0 | 6 | 3.55 ± 0.49 | 0.78 ± 0.19 | ||
RA: right atrium; LA: left atrium; P: power; RF: radiofrequency; T: temperature.
Figure 2Correlation of lesion lines obtained in virtual map and anatomic specimen. A: line on left atrium, epicardial correlation. B: line on left atrium, epicardial and endocardial correlation. C: line on right atrium between the inferior and superior vena cava shown on the endocardial surface.
Figure 3Histological aspect of the lesions. A: Lesion transmurality clearly demonstrated in smaller zoom (4X, H&E). B: Epicardial surface with fibrosis and discrete lymphocytic infiltrates (arrows) (10X, Masson). C: Presence of necrosis and thrombi clearly demonstrated (arrows) (5X, H&E). D: local inflammatory response characterized by infiltrate rich in lymphocyte-plasma cells and macrophages (giant cell, arrow) (40X, H&E).